Passage Bio Inc (PASG)
1.50
+0.03
(+2.04%)
USD |
NASDAQ |
May 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Passage Bio Total Assets (Quarterly): 150.54M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 150.54M |
| September 30, 2023 | 169.26M |
| June 30, 2023 | 193.70M |
| March 31, 2023 | 213.24M |
| December 31, 2022 | 243.55M |
| September 30, 2022 | 270.05M |
| June 30, 2022 | 299.42M |
| March 31, 2022 | 333.22M |
| December 31, 2021 | 355.08M |
| Date | Value |
|---|---|
| September 30, 2021 | 390.94M |
| June 30, 2021 | 439.52M |
| March 31, 2021 | 465.17M |
| December 31, 2020 | 328.01M |
| September 30, 2020 | 358.69M |
| June 30, 2020 | 378.10M |
| March 31, 2020 | 392.43M |
| December 31, 2019 | 178.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.54M
Minimum
Dec 2023
465.17M
Maximum
Mar 2021
303.50M
Average
328.01M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.26M |
| Shareholders Equity (Quarterly) | 111.28M |